A POTENTIAL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a formidable brain tumor known for its rapid growth and unresponsiveness to standard treatments. Research are constantly underway to identify new management strategies, and recently, a unique biomarker named click here LCA168 has emerged as a potential target for glioblastoma treatment. LCA168 is a protein that is highly expressed